Alzheimer’s disease (AD) and related dementias present significant challenges in therapeutic development, particularly within ...
The integration of multi-omics approaches in drug discovery is rapidly gaining momentum, offering a more comprehensive understanding of disease biology and paving the way for personalized medicine. A ...
The integration of bioinformatics, machine learning and multi-omics has transformed soil science, providing powerful tools to ...
A groundbreaking review in Biological Diversity proposes a proactive, AI - integrated approach to stop biological invasions ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Vizgen, Inc., a spatial multi-omics innovator accelerating biological discovery and new drug development, today announced that it will present new spatial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback